Gesynta Pharma AB’s SEK 190 Million Private Placement

Cirio advised Hadean Ventures, while represented Gesynta Pharma. Gesynta Pharma AB, a clinical-stage life company developing first-in-class therapeutics for chronic inflammatory conditions such as systemic sclerosis,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here